Delivery Order SPE2DB25D3017-SPE2DB25FVKTR
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 27, 2025, for the supply of Viberzi 100 mg tablets (60-count units) with a ceiling value of $2,130.52. This competitively awarded, non-set-aside contract reflects a firm fixed price delivery order with an ultimate completion date of August 28, 2025. The vendor will perform from its corporate office location in Conshohocken, Pennsylvania. This delivery order is executed under AmerisourceBergen Drug...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp, the pharmaceutical distributor and healthcare solutions provider headquartered in Conshohocken, Pennsylvania, on July 24, 2025, for the supply of Viberzi 100 mg tablets (60-count). This firm fixed price delivery order, valued at $1,184.87, is classified as a non-set-aside contract and is expected to reach ultimate completion by July 25, 2025, with performance occurring at AmerisourceBergen's Conshohocken...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 5, 2025, for the supply of Viberzi 100 mg tablets (60-count packages) with a ceiling value of $3,030.63. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. The order is scheduled for completion by June 6, 2025, and will...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 18, 2025, for the supply of Viberzi 75 mg tablets (60 count) valued at $2,354.21. This is a firm fixed price, competitively awarded contract with no set-aside designation and an ultimate completion date of June 20, 2025. The contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,960.49 to AmerisourceBergen Drug Corp for the supply of Viberzi 100 mg tablets (60-count) on July 15, 2025, with completion scheduled for July 16, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The place of performance is located in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $1,707.63 to AmerisourceBergen Drug Corp for the supply of Viberzi 100 mg tablets (60-count) on August 19, 2025, with an ultimate completion date of August 20, 2025. The contract utilizes firm fixed pricing and is classified as a non-set-aside competitive award. AmerisourceBergen, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location in the same city....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of VIBERZI 100 mg tablets (60-count). This $2,482.04 firm fixed-price delivery order represents a non-set-aside, competitively awarded contract with an ultimate completion date of August 15, 2025. The pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 18, 2025, for the supply of Viberzi 100 mg tablets (60-count) at a ceiling value of $3,587.92 under a firm fixed price contract. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The award was competitively determined with no...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 16, 2025, for the supply of Viberzi 100 mg tablets (60-count) with a ceiling value of $1,718.59. This is a firm fixed-price delivery order issued under a competitively awarded, non-set-aside procurement. The product will be delivered to the company's location in Conshohocken, Pennsylvania, with an ultimate completion date of September 17, 2025. This delivery order is issued as a child contract under...
- The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of Viberzi 75 mg tablets (60-count units) with a ceiling value of $2,002.01. This is a firm fixed-price delivery order with an ultimate completion date of August 8, 2025, and represents a non-set-aside competitive procurement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform this work at its corporate office location. The delivery...
- SPE2DB25D3017Indefinite Delivery Contract
- SPE2DB25D3017-SPE2DB25FVKTRDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 23, 2025, for the supply of Viberzi 100 mg tablets (60-count units) valued at $1,325.08. This is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, with an ultimate completion date of September 24, 2025. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical supply vehicle valued at $999,999,999.00 and extending through December 2026. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. The company's portfolio includes a wide range of pharmaceutical products and medical supplies across multiple therapeutic domains, delivered through competitively awarded contracts with the DLA. The Viberzi order under this delivery order represents a routine pharmaceutical procurement supporting the Defense Health Agency and other federal healthcare systems through the company's established prime vendor contract framework.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.3k | 9/23/25 |